P, C., GH, M., E, C., E, P., AL, B., TS, S., . . . DN, B. (2021). Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE. Journal of neuroimmunology, 352, 577468. https://doi.org/10.1016/j.jneuroim.2020.577468
Chicago Style (17th ed.) CitationP, Chaudhary, Marracci GH, Calkins E, Pocius E, Bensen AL, Scanlan TS, Emery B, and Bourdette DN. "Thyroid Hormone and Thyromimetics Inhibit Myelin and Axonal Degeneration and Oligodendrocyte Loss in EAE." Journal of Neuroimmunology 352 (2021): 577468. https://doi.org/10.1016/j.jneuroim.2020.577468.
MLA (9th ed.) CitationP, Chaudhary, et al. "Thyroid Hormone and Thyromimetics Inhibit Myelin and Axonal Degeneration and Oligodendrocyte Loss in EAE." Journal of Neuroimmunology, vol. 352, 2021, p. 577468, https://doi.org/10.1016/j.jneuroim.2020.577468.